Episode Player

A global market access journey in cannabinoid pharmaceuticals

Pharma Market Access Insights - from Petauri Evidence

Chapters
2:10
Your vision for the future of SOMAÍ Pharmaceuticals
4:36
Michael's career to date
7:28
The journey from discovery to getting cannabis licensed as a medical product
13:18
Challenges from regulators
24:21
The reimbursement picture
30:17
Benefit to patients and where these products offer potential
37:11
Patient perception of cannabinoid medicines
46:43
Lessons for the wider pharmaceutical industry
Pharma Market Access Insights - from Petauri Evidence
A global market access journey in cannabinoid pharmaceuticals
Jun 17, 2023 Season 5 Episode 1
Mtech Access

Send us Fan Mail

What does it take to bring a cannabinoid pharmaceutical to market?

We were delighted to welcome Michael Sassano (CEO – SOMAÍ Pharmaceuticals) as the first guest on our new Global Whispers webinar series. Michael shared with us his company’s experiences bringing new products to market, the challenges SOMAÍ Pharmaceuticals have faced and the lessons the Pharma industry can learn from their journey.

In the webinar, Clare asked Michael about:
- Drug development and clinical trial processes for medical cannabis products
 - Differences between the herbal medicines market and the Pharmaceutical market
 - Overcoming regulatory and reimbursement challenges
 - Finding the right place for cannabinoid medicines within existing pathways of care
 - Perceptions, pathways and routes to access in different markets
 - Lessons for the wider Pharma and Biotech industries

Learn more about this webinar and our guest speaker Michael Sassano at: https://mtechaccess.co.uk/global-market-access-journey-cannabinoid-pharmaceuticals/

Subscribe to our newsletter to hear more  news, insights and events from Petauri Evidence